Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Crotti

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Annals of the Rheumatic Diseases|November 12, 2020
Publishing in 2@84Marco Lanzillotta, Chiara Crotti, Vital Manuel Da Silva Domingues, et al.
Drug Design, Development and Therapy|July 20, 2017
A review of the literature analyzing benefits and concerns of infliximab biosimilar CT-P13 for the treatment of rheumatologic diseases: focus on interchangeabilityAndrea Becciolini, Maria Gabriella Raimondo, Chiara Crotti, et al.
Clinical Reviews in Allergy & Immunology|January 27, 2018
Sex and Management of Rheumatoid ArthritisEnnio Giulio Favalli, Martina Biggioggero, Chiara Crotti, et al.
Calcified Tissue International|July 1, 2024
Bone Turnover Markers and Wnt Signaling Modulators in Early Complex Regional Pain Syndrome. A Pre-specified Observational StudyMassimo Varenna, Francesco Orsini, Raffaele Di Taranto, et al.
Frontiers in Medicine|December 11, 2023
Effect of neridronate on axial involvement in patients with spondyloarthritis when biologics are not possible. Results of a monocentric studyChiara Crotti, Raffaele Di Taranto, Francesco Orsini, et al.
Drug Design, Development and Therapy|June 7, 2018
The role of concomitant methotrexate dosage and maintenance over time in the therapy of rheumatoid arthritis patients treated with adalimumab or etanercept: retrospective analysis of a local registryEnnio Giulio Favalli, Andrea Becciolini, Martina Biggioggero, et al.
Biology|October 27, 2023
Bone Involvement in Rheumatoid Arthritis and Spondyloartritis: An Updated ReviewFrancesco Orsini, Chiara Crotti, Gilberto Cincinelli, et al.
Therapeutic Advances in Musculoskeletal Disease|December 26, 2022
Long-term efficacy and safety of neridronate treatment in patients with complex regional pain syndrome type 1: a pre-specified, open-label, extension studyMassimo Varenna, Davide Gatti, Francesca Zucchi, et al.
Therapeutic Advances in Musculoskeletal Disease|June 28, 2021
Intramuscular neridronate for the treatment of complex regional pain syndrome type 1: a randomized, double-blind, placebo-controlled studyMassimo Varenna, Vania Braga, Davide Gatti, et al.
Autoimmunity Reviews|July 22, 2025
The assessment and management of bone health in pediatric-onset rheumatological diseases from early age to adulthood: A critical overviewRaffaele Di Taranto, Andrea Amati, Chiara Crotti, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Annals of the Rheumatic Diseases|November 12, 2020
Publishing in 2@84Marco Lanzillotta, Chiara Crotti, Vital Manuel Da Silva Domingues, et al.
Drug Design, Development and Therapy|July 20, 2017
A review of the literature analyzing benefits and concerns of infliximab biosimilar CT-P13 for the treatment of rheumatologic diseases: focus on interchangeabilityAndrea Becciolini, Maria Gabriella Raimondo, Chiara Crotti, et al.
Clinical Reviews in Allergy & Immunology|January 27, 2018
Sex and Management of Rheumatoid ArthritisEnnio Giulio Favalli, Martina Biggioggero, Chiara Crotti, et al.
Calcified Tissue International|July 1, 2024
Bone Turnover Markers and Wnt Signaling Modulators in Early Complex Regional Pain Syndrome. A Pre-specified Observational StudyMassimo Varenna, Francesco Orsini, Raffaele Di Taranto, et al.
Frontiers in Medicine|December 11, 2023
Effect of neridronate on axial involvement in patients with spondyloarthritis when biologics are not possible. Results of a monocentric studyChiara Crotti, Raffaele Di Taranto, Francesco Orsini, et al.
Drug Design, Development and Therapy|June 7, 2018
The role of concomitant methotrexate dosage and maintenance over time in the therapy of rheumatoid arthritis patients treated with adalimumab or etanercept: retrospective analysis of a local registryEnnio Giulio Favalli, Andrea Becciolini, Martina Biggioggero, et al.
Biology|October 27, 2023
Bone Involvement in Rheumatoid Arthritis and Spondyloartritis: An Updated ReviewFrancesco Orsini, Chiara Crotti, Gilberto Cincinelli, et al.
Therapeutic Advances in Musculoskeletal Disease|December 26, 2022
Long-term efficacy and safety of neridronate treatment in patients with complex regional pain syndrome type 1: a pre-specified, open-label, extension studyMassimo Varenna, Davide Gatti, Francesca Zucchi, et al.
Therapeutic Advances in Musculoskeletal Disease|June 28, 2021
Intramuscular neridronate for the treatment of complex regional pain syndrome type 1: a randomized, double-blind, placebo-controlled studyMassimo Varenna, Vania Braga, Davide Gatti, et al.
Autoimmunity Reviews|July 22, 2025
The assessment and management of bone health in pediatric-onset rheumatological diseases from early age to adulthood: A critical overviewRaffaele Di Taranto, Andrea Amati, Chiara Crotti, et al.
Pageof 5